top of page

GSK Oral Solid Dose Facility 

Project Description:

 

M2 Build is an Oral Solid Dose facility (OSD), producing tablets and capsules for the GSK brand. 

 

The project was a blend of modular design (DFMA) and traditional ‘stick built’ construction.

 

Should you wish to know more about our role on Science Research and Healthcare projects, please contact hello@iM2ltd.com

Key Challenges:

  • Providing a GMP environment

  • DFMA Modular Design

iM2 Role: Principal Designer

Project Team:

GSK

Simons Design Ltd

Shepherd Gilmore

NG Bailey

GSK

Sector: Science, Research & Healthcare

Start Date: July 2020

Completion: January 2023

Value: (£) Confidential

Screenshot 2021-09-22 at 17.28.17.png
Screenshot 2021-09-22 at 17.28.26.png
Screenshot 2021-09-22 at 17.28.35.png
Screenshot 2021-09-22 at 17.28.09.png
APS-logo White.jpg
iirsm_main_logo.jpg
iM2 Limited
The Stanley Building
7 Pancras Square
London, N1C 4AG
England, UK
  • X
  • LinkedIn

www.iM2ltd.com

0203 972 4157

CIOB-Logo.jpg
IOSH-Logo.jpg
iM2 LOGO ISSUE A OUTLINES 25-05-20.png
bottom of page